• α-Amanitin: Precision Tool for RNA Polymerase II Assays

  2026-05-02

  α-Amanitin’s unrivaled specificity for RNA polymerase II makes it indispensable for dissecting transcriptional regulation and gene expression pathways in both developmental and disease models. This guide details experimental workflows, troubleshooting, and the latest mechanistic insights—empowering researchers to optimize results using APExBIO’s high-purity α-Amanitin.

• Foretinib (GSK1363089): Multikinase Inhibition in Cancer Res

  2026-05-02

  Foretinib (GSK1363089) is a potent ATP-competitive inhibitor targeting VEGFRs and MET, offering robust suppression of tumor cell proliferation and metastasis. Its low nanomolar IC50 values and efficacy in multiple cancer models position it as a key tool for translational oncology research.

• Poly (I:C): Synthetic dsRNA Analog for Advanced Immune Activ

  2026-05-01

  Poly (I:C), the benchmark synthetic double-stranded RNA analog, enables precise stimulation of innate immune pathways and dendritic cell maturation for cutting-edge immunology and antiviral research. This guide details practical workflows, experimental enhancements, and troubleshooting strategies to maximize its impact in both basic and translational applications.

• Epalrestat in Translational Parkinson’s Research: Mechanisti

  2026-04-30

  Explore how Epalrestat, a potent aldose reductase inhibitor, advances Parkinson’s disease and oxidative stress research through direct KEAP1 targeting. This article provides a protocol-centric, mechanistic perspective not found in existing reviews.

• Gentamycin Sulfate: Optimizing Protein Synthesis and Resista

  2026-04-30

  Gentamycin Sulfate from APExBIO empowers researchers to model bacterial protein synthesis inhibition and dissect antibiotic resistance mechanisms in Gram-negative pathogens. This guide offers actionable protocols, workflow enhancements, and troubleshooting strategies, translating the latest resistance epidemiology into practical assay design.

• CLCC1 Identified as Key Host Factor in Herpesvirus Nuclear E

  2026-04-29

  A recent study uncovers CLCC1 as a critical host mediator of membrane fusion during herpesvirus nuclear egress, revealing a previously unknown cellular mechanism essential for viral replication. These insights clarify a major step in the herpesvirus life cycle and suggest new avenues for antiviral research and immunomodulation.

• Butyrate Drives Ferroptosis to Limit Lung Cancer Stemness vi

  2026-04-29

  This study elucidates how butyrate induces ferroptosis in lung cancer stem cells by recruiting lysosomal Fe2+ and promoting SLC7A11 degradation. The findings highlight a novel metabolic vulnerability in lung CSCs, with implications for targeted cancer therapies.

• FLAG tag Peptide (DYKDDDDK): Mechanistic Impact on Chromatin

  2026-04-28

  Discover how the FLAG tag Peptide (DYKDDDDK) revolutionizes chromatin and HDAC complex research. This article unpacks its mechanistic integration in advanced recombinant protein detection, highlighting unique insights not found in standard guides.

• 17-AAG (Tanespimycin): Precision HSP90 Inhibition and Apopto

  2026-04-28

  Explore how 17-AAG (Tanespimycin) precisely disrupts HSP90 chaperone function and orchestrates regulated apoptosis in cancer models. This article uniquely bridges advanced molecular mechanisms and the latest insights from virology, offering researchers practical guidance for translational oncology.

• Nirmatrelvir (PF-07321332): Molecular Insights for SARS-CoV-

  2026-04-27

  Explore the molecular underpinnings of Nirmatrelvir (PF-07321332) as a SARS-CoV-2 3CL protease inhibitor. This article offers advanced assay guidance and bridges in silico findings with experimental antiviral therapeutics research.

• Ferroelectric-Liquid Metal Hybrid Photoreceptors for Retinal

  2026-04-27

  This study develops a ferroelectric-liquid metal hybrid film that mimics human visual adaptation, enabling broad-spectrum photoelectric response for use as an artificial retinal prosthesis. The device restored vision in rodent models of retinal degeneration, highlighting a promising direction for next-generation bioelectronic implants.

• DiscoveryProbe Bioactive Compound Library Plus in High-Throu

  2026-04-26

  The DiscoveryProbe Bioactive Compound Library Plus empowers researchers with 5,072 rigorously validated, cell-permeable compounds, ready for advanced high-throughput screening. This article delivers actionable workflows, troubleshooting advice, and strategic insights to accelerate target validation and pathway analysis across cancer, immunology, and signal transduction research.

• Vorinostat for Epigenetic Modulation in Oncology Research

  2026-04-25

  Vorinostat (suberoylanilide hydroxamic acid, SAHA) delivers precise epigenetic control and robust apoptosis induction, enabling advanced workflows in cancer biology. This article translates core mechanistic and workflow evidence into actionable protocols and troubleshooting strategies for HDAC inhibitor use in experimental oncology.

• GSK621: AMPK Agonist for AML and Immunometabolic Workflows

  2026-04-24

  GSK621 delivers precise, potent AMPK activation for advanced acute myeloid leukemia and immunometabolic research. Its selectivity, robust in vitro and in vivo efficacy, and compatibility with autophagy and apoptosis assays set it apart for metabolic pathway interrogation.

• Cathepsin S in Lymphoma: Antigen Processing and T Cell Cross

  2026-04-24

  Dheilly et al. (2020) uncover how cathepsin S (CTSS) overexpression and mutation alter antigen presentation and immune cell dynamics in non-Hodgkin lymphoma. Their findings show that CTSS activity shapes tumor-immune interactions and suggest that targeted cysteine protease inhibition could enhance anti-tumor immunity in lymphoma.

16528 records 1/1102 page Next 12345 下5页 Last page